Grand opening of state-of-the-art R&D facility
DULUTH, Ga. , Oct. 24, 2024 /PRNewswire/ — Boehringer Ingelheim announced the grand opening of its newly expanded research and development facility in Athens, Georgia. This state-of-the-art facility from Boehringer, Georgia’s largest animal health company, reflects the company’s commitment to innovation and improving animal health and welfare.
Boehringer Ingelheim logo (PRNewsfoto/Boehringer Ingelheim)
With a capital investment of $66.1 million and the creation of 63 new jobs, the expansion includes the addition of 63,000 square feet of administrative space and more than 28,000 square feet of laboratory space in Athens-Clarke County. This expansion sets the stage for breakthrough discoveries and serves as a beacon of creativity across all disease areas and treatments, shaping the future of animal health.
“Our new research and development facility in Athens is an important milestone in our commitment to animal health innovation,” said Peter Ploeger, U.S. country managing director for animal health at Boehringer Ingelheim. “Each year, we invest nearly 12 percent of our sales into research and development of products that improve the health of animals, especially pets, for generations to come.”
Boehringer’s Athens expansion facility will be the company’s largest research and development site in the United States and third largest in the world. This sustainability-focused facility houses the company’s U.S. Global Innovation Hub. It is also Boehringer’s largest pet vaccine production facility in the United States and a major manufacturing site for poultry and wildlife vaccines.
Georgia Department of Economic Development Secretary Pat Wilson emphasized, “Today’s expansion represents an opportunity to retain Georgia’s highly educated and diverse workforce.” “Boehringer Ingelheim’s presence in Georgia strengthens the local economy and is particularly well-suited to the statewide ecosystem for life sciences, research and innovation.”
The decision to expand into Athens-Clarke County was based on multiple factors, including proximity to the USDA’s National Poultry Research Center and the University of Georgia, supporting career academies, and a newly created partnership with Athens-Clarke County. was influenced by. Biomanufacturing pathway. These community partnerships provide unique opportunities for strategic collaboration with talented individuals that support education and innovation in animal health.
“Georgia is one of the nation’s leading poultry producers, and the collaboration between the Georgia Department of Agriculture, Boehringer Ingelheim, the University of Georgia, and the Department of Agriculture will put Georgia at the forefront of animal health and poultry disease research. ” said the Georgia Department of Agriculture. Commissioner Tyler Harper. “We are grateful for Boehringer Ingelheim’s commitment to Georgia and the Athens-Clarke County community and look forward to continuing to work together to ensure the health of animals and the security of Georgia’s food supply. There is.”
story continues
“Boehringer Ingelheim’s expansion is important to Athens-Clarke County,” said Kelly Gertz, Mayor of the United Athens-Clarke County Government. “Their commitment to sustainability and innovative solutions aligns perfectly with our city’s core values. Build local partnerships that promote environmentally friendly practices and energy-efficient technologies. This will positively impact job growth and strengthen our communities.”
This expansion is made possible through a partnership with the Georgia Department of Economic Development, Invest Athens, the Metro Atlanta Chamber of Commerce, and Georgia Power.
About Boehringer Ingelheim Animal Health USA Inc.
Boehringer Ingelheim Animal Health is committed to first-in-class innovations to predict, prevent and treat animal diseases. We serve veterinarians, pet owners, producers, and governments in more than 150 countries with a large, innovative portfolio of products and services to improve the health and well-being of companion animals and livestock. Masu.
As a world leader in the animal health industry and part of the family-owned Boehringer Ingelheim, we take a long-term perspective. Animal and human lives are deeply and intricately connected. We know that when animals are healthy, humans are also healthier. By leveraging the synergies between our Animal Health and Human Pharma businesses and delivering value through innovation, we enhance the health and well-being of both.
Media Contact: Jaclyn Allison
Communications and PR Manager, Animal Health
Phone (678)230-3817
Jaclyn.Allison@boehringer-ingelheim.com
Sision
View original content to download multimedia: https://www.prnewswire.com/news-releases/boehringer-ingelheim-expands-research-and-development-in-athens-georgia-302286462. html
Source Boehringer Ingelheim
